Manufactured Object – Page 27

Novartis to Revise CRO Partnerships Amidst US Senate Bill Scrutiny

12 months ago talkbio0Tagged Chinese Language, CRO, Drug Industry, Novartis, Partnership, regulatory, Relationships, Revisions, Senate

Novartis, CRO relationships, US Senate bill, Chinese companies, pharmaceutical industry, regulatory changes, partnership revisions

Senator Sanders Investigates Skyrocketing Costs of Novo Nordisk’s Diabetes and Weight Loss Drugs

12 months ago talkbio0Tagged Affordability, Diabetes, Evaluation, Health care facility, Nordisk, Novos, Prices, Senator Bernie Sanders, Wegovy

Senator Bernie Sanders, Novo Nordisk, diabetes, weight loss, drug prices, Novos Ozempic, Wegovy, investigation, healthcare costs, affordability

Biogen’s Leqembi Gains Momentum: A Steady Pace in Market Growth

1 year ago talkbio0Tagged Alzheimer 's disease, Approved, Biogen, Clinical Trials, Growth, Health care facility, Leqembi, Market, Neurology speciality, United States Food and Drug Administration

Biogen, Leqembi, Alzheimer’s disease, clinical trials, FDA approval, market growth, steady pace, neurology, healthcare, pharmaceuticals.

Novartis Boosts 2024 Sales Forecast, Gears Up for Major Cancer Drug Expansions

1 year ago talkbio0Tagged 2024, cancer drugs, drug expansions, Drug Industry, Health care facility, Neoplasms, Novartis, Sales - occupational activity

Novartis, 2024 sales outlook, cancer drugs, drug expansions, pharmaceutical industry, healthcare, oncology.

Xaira: The Billion-Dollar AI-Powered Drug Discovery Startup Revolutionizing Healthcare

1 year ago talkbio0Tagged AI, Artificial Intelligence, Biotechnology, Drug Discovery, Health care facility, startup, Xaira

Xaira, AI, drug discovery, healthcare, startup, funding, billion-dollar, revolutionizing, pharmaceuticals, biotechnology.

Novartis Appoints Ex-Bristol Myers CEO Giovanni Caforio as Chair: Potential for Future M&A Deals?

1 year ago talkbio0Tagged Acquisitions, Chairs, Corporate, Drug Industry, Giovanni Caforio, Leadership Change, M&A, mergers, Myers, Novartis

Novartis, Bristol Myers, Giovanni Caforio, Chair, Mergers and Acquisitions (M&A), Pharmaceutical Industry, Corporate Strategy, Leadership Change.

Sanofi’s Strategic Acquisition of Principia Bears Fruit with Rilzabrutinib’s Phase III Success

1 year ago talkbio0Tagged Acquisition (action), Biotechnology, Clinical Trials, Drug Development, Drug Industry, Investments, Phase III, Principia, Rilzabrutinib, sanofi, strategic, Success

Sanofi, Principia, acquisition, Rilzabrutinib, Phase III, clinical trial, success, strategic investment, pharmaceutical industry, biotechnology, drug development.

Revolutionizing Women’s Healthcare: GE HealthCare Unveils AI-Driven, Voice-Activated Ultrasound Machines

1 year ago talkbio0Tagged AI-powered, Diagnostic Imaging, Discipline of obstetrics, Gynecology, Health care facility, healthcare innovation, medical technology, ultrasound machines, voice-activated, women 's health

GE HealthCare, voice-activated, AI-powered, ultrasound machines, women’s health, healthcare innovation, medical technology, diagnostic imaging, obstetrics, gynecology.

BMS Expands CAR-T Therapy Capabilities with Strategic $380 Million Investment in Cellares

1 year ago talkbio0Tagged Automation, Biotechnology, Burning Mouth Syndrome, Cancer Therapeutic Procedure, Capacity, CAR-T, Cell Therapy, Cellares, expansion, Investments, Manufacture, squibb

BMS, Bristol Myers Squibb, Cellares, CAR-T therapy, cell therapy, cancer treatment, biotechnology, investment, capacity expansion, manufacturing, automation.

AbbVie Emerges as Leading Immunology Company in Doctor Rankings, Surpassing Pfizer and Johnson & Johnson

1 year ago talkbio0Tagged AbbVie, Drug Industry, Immunology, Johnson & Johnson, Market, Performance, Pfizer, Physicians, portfolio, product, reputation

AbbVie, Pfizer, Johnson & Johnson, doctor ranking, immunology companies, pharmaceutical industry, market performance, reputation, product portfolio.